Prolocor: Funding, Investors & Team (Oct 2026)
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.
Prolocor has raised $3.2M across 1 funding round on record, the most recent a Seed of $3.2M announced in Aug 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Prolocor Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Prolocor Funding Rounds
Prolocor Founders and Leadership Team
No contact details are on record for this team yet.
Prolocor Funding Compared to Other Biotechnology Startups
Prolocor's latest round of $3.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Prolocor in Biotechnology and Philadelphia
Companies Similar to Prolocor
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Prolocor Funding FAQs
What does Prolocor do?
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.
How much funding has Prolocor raised?
Prolocor has raised $3.2M across 1 round on record. The most recent is a Seed of $3.2M announced in Aug 2022.
When did Prolocor last raise funding?
Prolocor's most recent funding round on record is a Seed of $3.2M, announced in Aug 2022.
Who is the CEO of Prolocor?
Peter Dibattiste is listed as CEO at Prolocor.
Where is Prolocor headquartered?
Prolocor is based in Philadelphia, Pennsylvania, United States.
How many employees does Prolocor have?
Prolocor is in the 1-10 employee band.
How does Prolocor's funding compare to other Biotechnology startups?
Prolocor's latest round of $3.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Prolocor Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Prolocor is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.